Last reviewed · How we verify
NCT07477054: AERO-PAS
A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System
NA trial testing Lungpacer Diaphragm Pacing Therapy in Ventilator Induced Diaphragm Dysfunction in 120 participants. Not yet recruiting.
1 February 2028
Quick facts
| Lead sponsor | Lungpacer Medical Inc. |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 July 2026 |
| Primary completion | 1 February 2028 |
| Estimated completion | 1 February 2028 |
Drugs / interventions tested
- Lungpacer Diaphragm Pacing Therapy
Conditions studied
- Ventilator Induced Diaphragm Dysfunction — all drugs for Ventilator Induced Diaphragm Dysfunction →
Sponsor
Lungpacer Medical Inc. — full company profile →
Who can join
18 and older, any sex, with Ventilator Induced Diaphragm Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A single-arm, prospective, multicenter cohort study to assess the 30-day continued safety and effectiveness of the AeroPace System in patients on mechanical ventilation (MV) at least 96 hours and who have not weaned. This is a study collecting real-world data in a post-market setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07477054
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lungpacer Diaphragm Pacing Therapy
Trials testing the same drug.
- NCT03783884 — A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation · NA · terminated
Other Lungpacer Medical Inc. trials
Trials by the same sponsor.
- NCT04844892 — Phrenic Nerve Stimulation-Induced Lung ReAeration Trial · NA · completed
- NCT03783884 — A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation · NA · terminated
- NCT03659552 — Percutaneous Temporary Placement of a Transvenous Phrenic Nerve Stimulator for Diaphragm Pacing Using Jugular Access · NA · completed
- NCT03096639 — Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing · NA · completed
- NCT03107949 — Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing (RESCUE1) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07477054 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lungpacer Medical Inc.
- Last refreshed: 17 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07477054.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing